St. Luke’s Participates In COVID-19 Study Conducted By CDC
DULUTH, Minn. – St. Luke’s hospital is one of six national healthcare organizations and the only in Minnesota taking part in a study conducted by the Centers for Disease Control and Prevention.
The study is an opportunity to learn more about COVID-19, which could be beneficial for the treatment of the virus.
There are still many questions surrounding the coronavirus, and about the ongoing global pandemic.
Health professionals at St. Luke’s hospital are ready to do their part to find some answers.
The study involves enrolling up to 500 healthcare workers within St. Luke’s Hospital.
Each person participating in the research will be tested for COVID-19 every week for the next year.
Throughout the evaluation period, they will also be asked to have their blood tested for antibodies.
The intent is to find explanations for so many unanswered questions health professionals worldwide are working hard to figure out.
“I want to know if people can be infected a second time. I want to know if the antibodies last a long time. I want to know if a vaccine will be durable and will be able to protect people or if you can get sick with or without antibodies. I think those are questions we have to be able to answer,” said Dr. Harmony Tyner, an infectious disease specialist for St. Luke’s.
One of the major goals for the study is to create a large demographic that includes people of different races, ages, and genders.
Health experts at St. Luke’s believe their participation in the study may also be adding a different perspective than the other organizations involved due to Minnesota’s large rural community.
The big picture is to help find solutions for a health crisis that has taken over the world and hopefully assist in finding new ways to start returning life back to normal.
So far about 100 St. Luke’s employees have already started participating in the study.